Chromogranin A levels in chronic liver disease and hepatocellular carcinoma
- 31 January 2009
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 41 (1) , 31-35
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter StudyEndocrine-Related Cancer, 2007
- Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotideBritish Journal of Cancer, 2006
- Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinomaGut, 2004
- Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis CAnnals of Internal Medicine, 2003
- The Chromogranin–Secretogranin FamilyNew England Journal of Medicine, 2003
- Evidence base of clinical diagnosis: The architecture of diagnostic researchBMJ, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Hepatocellular carcinoma: is surveillance cost effective?Gut, 2001
- Chromogranin A Expression in Hepatocellular Carcinoma in a Patient with Germline MEN1 Gene Mutation.Internal Medicine, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999